SOL (SOLM) Stock Overview

Engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. More details

SOLM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 9.93% per year

Earnings grew by 10.8% over the past year

Risk Analysis

Shares are highly illiquid

SOLM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

SOL S.p.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for SOL
Historical stock prices
Current Share Price	€50.90
52 Week High	€50.90
52 Week Low	€36.70
Beta	0.71
1 Month Change	5.17%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	343.57%
Change since IPO	675.91%

Recent updates

Shareholder Returns

	SOLM	GB Chemicals	GB Market
7D	0%	2.9%	1.8%
1Y	n/a	-14.0%	13.1%

Return vs Industry: Insufficient data to determine how SOLM performed against the UK Chemicals industry.

Return vs Market: Insufficient data to determine how SOLM performed against the UK Market.

Price Volatility

Is SOLM's price volatile compared to industry and market?
SOLM volatility
SOLM Average Weekly Movement	n/a
Chemicals Industry Average Movement	6.2%
Market Average Movement	4.7%
10% most volatile stocks in GB Market	10.8%
10% least volatile stocks in GB Market	2.4%

Stable Share Price: SOLM's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine SOLM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1927	7,412	Aldo Romario	www.solgroup.com

SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company offers oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, gaseous and liquid helium, gas for electronics, ammonia and combustible gases, and liquefied natural gas. It also provides medical gases with AIC and medical devices; training services; InfoHealth SOLution, a web platform that control plans, coordinate, and manage all the activities carried out within the healthcare facilities; electromedical equipment services; hospital hygiene and environmental monitoring; total ambulance management; and design and development of biobanks services.

SOL S.p.A. Fundamentals Summary

How do SOL's earnings and revenue compare to its market cap?
SOLM fundamental statistics
Market cap	€4.59b
Earnings (TTM)	€156.30m
Revenue (TTM)	€1.73b

29.4x

P/E Ratio

2.6x

P/S Ratio

Is SOLM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SOLM income statement (TTM)
Revenue	€1.73b
Cost of Revenue	€1.32b
Gross Profit	€416.80m
Other Expenses	€260.51m
Earnings	€156.30m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	1.72
Gross Margin	24.03%
Net Profit Margin	9.01%
Debt/Equity Ratio	60.3%

How did SOLM perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

23%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/07 00:28
End of Day Share Price	2025/09/29 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SOL S.p.A. is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Paola Saglietti	Banca Akros S.p.A. (ESN)
Catharina Claes	Berenberg
Giovanni Selvetti	Berenberg

SOL S.p.A.BATS-CHIXE:SOLM Stock Report